# Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects

> **NCT05176210** · PHASE1 · UNKNOWN · sponsor: **Pharmasaga Co. Ltd.** · enrollment: 64 (estimated)

## Conditions studied

- Type II Diabetes

## Interventions

- **DRUG:** PS1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05176210
- **Lead sponsor:** Pharmasaga Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-22
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05176210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05176210, "Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05176210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*